1. Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984; 148: 951-63.
3. Nakayama T, Nakayama H, Miyamoto M, Hamlin RL. Hemodynamic and electrocardiographic effects of magnesium sulfate in healthy dogs. J Vet Intern Med 1999; 13: 485-90.
5. Yoshida A, Itoh Y, Nagaya K, Takino K, Sugawara J, Murakami T, et al. Prolonged relaxant effects of vecuronium in patients with deliberate hypermagnesemia: time for caution in cesarean section. J Anesth 2006; 20: 33-5.
6. Kim JS, Ryu TG, Kong MH, Lee MK, Yoon SM. The effects of magnesium on pipecuronium-induced neuromuscular blockade and its reversal in the isolated rat phrenic nerve-hemidiaphragm. Korean J Anesthesiol 1996; 31: 150-5.
7. Koo EH, Yoon SM, Hwang KH, Kim SY. The effect of sium on the onset time of rocuronium-induced neuromuscular blockade in the isolated rat phrenic nerve-hemidiaphragm. Korean J Anesthesiol 1999; 37: 467-71.
8. Czarnetzki C, Lysakowski C, Elia N, Tramèr MR. Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomised study. Acta Anaesthesiol Scand 2010; 54: 299-306.
10. Bom A, Hope F, Rutherford S, Thomson K. Preclinical pharmacology of sugammadex. J Crit Care 2009; 24: 29-35.
11. Unterbuchner C, Ziegleder R, Graf B, Metterlein T. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex. Acta Anaesthesiol Scand 2015; 59: 536-40.
12. Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. Clin Pharmacokinet 2000; 38: 305-14.
13. Lee YK, Park SK, Kim JW, Yang HS, Han SM. Effects of phenytoin on rocuronium-induced neuromuscular blockade using a rat phrenic nerve-diaphragm preparation. Korean J Anesthesiol 2003; 45: 244-50.
15. Czarnetzki C, Tassonyi E, Lysakowski C, Elia N, Tramèr MR. Efficacy of sugammadex for the reversal of moderate and deep rocuroniuminduced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial. Anesthesiology 2014; 121: 59-67.
19. Waud BE, Waud DR. The relation between the response to "train-of-four" stimulation and receptor occlusion during competitive neuromuscular block. Anesthesiology 1972; 37: 413-6.
20. Hans GA, Bosenge B, Bonhomme VL, Brichant JF, Venneman IM, Hans PC. Intravenous magnesium re-establishes neuromuscular block after spontaneous recovery from an intubating dose of rocuronium: a randomised controlled trial. Eur J Anaesthesiol 2012; 29: 95-9.
22. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109: 389-98.
23. Abad-Gurumeta A, Ripollés-Melchor J, Casans-Francés R, Espinosa A, Martínez-Hurtado E, Fernández-Pérez C, et al. A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade. Anaesthesia 2015; 70: 1441-52.
24. Staals LM, Driessen JJ, Van Egmond J, De Boer HD, Klimek M, Flockton EA, et al. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex. Acta Anaesthesiol Scand 2011; 55: 700-7.
25. Jonsson M, Gurley D, Dabrowski M, Larsson O, Johnson EC, Eriksson LI. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade. Anesthesiology 2006; 105: 521-33.